Home
Home | About | Credits | Seminar List | Poster | Feedback   System Requirements | Subscribe to ASCB iBioSeminars RSS Feed

Previous Part Tuberculosis: A Persistent Threat to Global Health
John D. McKinney, June 2007
Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL)
Next Part
Lecture Overview
The principal obstacle to successful treatment of tuberculosis is the lengthy duration of current regimens, which require administration of multiple drugs for 6-9 months. The requirement for prolonged therapy is attributed to sub-populations of bacillary "persisters" that are refractory to antimicrobials. The persisters are not drug-resistant in the conventional (heritable) sense and it is a mystery why they are spared whilst their genetically identical siblings are killed. The third part of this lecture describes recent work in our laboratory using microfluidics and time-lapse microscopy to analyze the behavior of drug-stressed bacteria at single-cell resolution. These studies challenge conventional views of how antimicrobials kill (or fail to kill) bacteria.

Part 3: Phenotypic Heterogeneity and Antibiotic Tolerance (27:15)
  • Click image above to start seminar in 320x240 format
  • Click here to view in larger 640x480 format*

      QuickTime 7 Required    *640x480 System Requirements
    (there may be a few seconds delay before seminars start)



    Downloads in alternative formats:
    (To Save, Right Click a link below and select "Save Target/Link As")

    QuickTime (51mb)     MP4 (319mb)     iPod/iPhone Video (319mb)
    PowerPoint Slides 1/page (392kb)     PowerPoint Slides 6/page (208kb)

    Format Descriptions
    Download Accelerator/Resume Broken Downloads Software

  • Part 1: Tuberculosis: The Once and Future Plague (27:33)

     


    Part 2: Tools for Tuberculosis Control: Not Just a Problem of Implementation (28:18)

     

    Part 4: Targeting M. tuberculosis Carbon Metabolism In Vivo (26:12)



    Speaker Bio    Related Articles